Rocket


Overview
Financials
News + Filings





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

CEN BIOTECH INC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/19/2019 10-Q Quarterly Report for the period ended June 30, 2019
08/14/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/21/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Form of Merger Agreement dated June 21, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp. and Caduceus Merger Sub, Inc",
"WINDSOR, ON, June 21, 2019 – On June 21, 2019, CEN Biotech, Inc. entered into a Merger Agreement with Caduceus Software Systems Corp., a Wyoming corporation , which was reviewed and approved by the Board of Directors of CEN on June 21, 2019. This transaction follows the signing of a Non-Binding Term Sheet with CSOC on May 15, 2019, in which, CEN and CSOC agreed to undertake a merger transaction to combine the two companies’ operations and negotiate and enter into a definite agreement to affect the transaction. According to Joseph Byrne, CEO of CEN Biotech Inc., “We believe that this Merger Agreement is a major milestone in completing the transaction with CSOC to create a combined company that, we believe, can create value for both CEN and CSOC shareholders.” According to the signed Merger ..."
05/22/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Email Letter to Convertible Note Holders (furnished herewith)"
05/20/2019 10-Q Quarterly Report for the period ended March 31, 2019
05/16/2019 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Term Sheet dated May 15, 2019, between CEN Biotech, Inc. and Caduceus Software Systems Corp",
"WINDSOR, ON, May 16, 2019 – On May 15, 2019, CEN Biotech, Inc. entered into a Non-Binding Term Sheet with Caduceus Software Systems Corp., a Wyoming corporation , which was reviewed and approved by the Board of Directors of CEN on May 15, 2019. Pursuant to the Term Sheet, CEN and CSOC agreed to undertake a merger transaction to combine the two companies’ operations and negotiate and enter into a definite agreement to affect the transaction. According to Joseph Byrne, CEO of CEN Biotech Inc., “It is planned that CEN and CSOC will engage in a merger transaction whereby CSOC will create a new wholly owned subsidiary and CEN will become a wholly owned subsidiary of CSOC. We are very pleased with the direction of this transaction and we believe that it will create value for both CEN and CSOC sh..."
05/16/2019 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Executive Employment Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain",
"Restricted Stock Agreement dated May 16, 2019, between CEN Biotech, Inc. and Alex Tarrabain"
05/14/2019 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/16/2019 10-K Annual Report for the period ended December 31, 2018
04/08/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment dated April 3, 2019, to Share Purchase Agreement dated August 31, 2016, and executed September 12, 2016, as amended, between CEN Biotech, Inc. and Stevan Pokrajac and Tesla Digital Inc. and Tesla Digital Global Group Inc"
03/26/2019 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/26/2019 D Form D - Notice of Exempt Offering of Securities:
11/30/2018 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Share Repurchase Agreement, executed as of November 27, 2017, by and between James L. Robinson and CEN Biotech Inc"
11/13/2018 10-Q Quarterly Report for the period ended September 30, 2018
10/09/2018 8-K Quarterly results
08/14/2018 10-Q Quarterly Report for the period ended June 30, 2018
08/06/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Share Purchase Agreement"
06/12/2018 8-K Appointed a new director
05/21/2018 10-Q Quarterly Report for the period ended March 31, 2018
05/14/2018 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/17/2018 10-K/A Annual Report for the period ended December 31, 2017 [amend]
04/16/2018 10-K Annual Report for the period ended December 31, 2017
04/16/2018 8-K Quarterly results
03/30/2018 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
01/17/2018 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter re: CEN Biotech, Inc."
12/14/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Controlling Interest Purchase Agreement"
12/12/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Share Repurchase Agreement"
12/05/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement of Bahige (Bill) Chaaban and Cen Biotech Inc",
"Executive Employment Agreement of Joseph Byrne and Cen Biotech Inc",
"Executive Employment Agreement of Richard Boswell and Cen Biotech Inc",
"Executive Employment Agreement of Brian Payne and Cen Biotech Inc",
"2017 Equity Compensation Plan",
"Form of Restricted Stock Agreement for US Persons",
"Form of Restricted Stock Agreement for Canadian Persons"
11/20/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/13/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/28/2017 8-K Quarterly results
08/21/2017 10-Q Quarterly Report for the period ended June 30, 2017
08/14/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
07/18/2017 8-K Form 8-K - Current report:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy